MarketPulse

peripheral vascular disease

2 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

LeMaitre Vascular Surges 30% Despite Insider Sale as Strong Results Drive Confidence

LeMaitre Vascular stock rises 30% annually after Q4 results showed 16% sales growth and 47% operating income gains, despite a senior executive selling $285K in shares.
LMATperipheral vascular diseaseearnings growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

LeMaitre Vascular to Present at Five Major Healthcare Investment Forums in March

LeMaitre Vascular will present at five major healthcare investment conferences in March 2026, engaging with institutional investors and analysts about corporate strategy and growth opportunities.
LMATinvestor conferencesvascular devices